Stoke Therapeutics (STOK) FCF Margin (2022 - 2026)
Stoke Therapeutics' (STOK) quarterly FCF Margin came in at 978.25% in Q1 2026, down 106137.0% year-on-year from N/an in Q1 2025, and up 55.8% quarter-over-quarter from 2213.41% in Q4 2025.
Stoke Therapeutics (STOK) FCF Margin (2022 - 2026) Analysis & Trends
Stoke Therapeutics' FCF Margin history runs 5 years deep, the most recent figure standing at 978.25% for Q1 2026.
- On a quarterly basis, FCF Margin fell 106137.0% year-over-year to 978.25% in Q1 2026; TTM through Mar 2026 was 460.79%, a 49710.0% decrease from a year earlier, with the FY2025 full-year figure at 24.35%, up 26250.0% from the prior year.
- FCF Margin rose to 978.25% in Q1 2026 per STOK's latest filing, from 2213.41% in the prior quarter.
- Across five years, FCF Margin topped out at 1055.0% in Q1 2022 and bottomed at 2213.41% in Q4 2025.
- The 5-year median for FCF Margin is 533.4% (2023), against an average of 509.38%.
- Biggest YoY gain for FCF Margin was 66595 bps in 2025; the steepest drop was 211000 bps in 2025.
- Year by year, FCF Margin stood at 675.89% in 2022, then decreased by 10 bps to 745.11% in 2023, then surged by 86 bps to 103.41% in 2024, then plunged by 2040 bps to 2213.41% in 2025, then surged by 56 bps to 978.25% in 2026.
- Per Business Quant, the three latest STOK FCF Margin figures stand at 978.25% (Q1 2026), 2213.41% (Q4 2025), and 286.0% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Stoke Therapeutics | 1.87 Bn | 1.53 Bn | - | -978.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -978.25% |
| Dec 31, 2025 | -2,213.41% |
| Sep 30, 2025 | -286.00% |
| Jun 30, 2025 | -184.16% |
| Mar 31, 2025 | 83.12% |
| Dec 31, 2024 | -103.41% |
| Sep 30, 2024 | -440.70% |
| Jun 30, 2024 | -362.84% |
| Mar 31, 2024 | -582.83% |
| Dec 31, 2023 | -745.11% |
| Sep 30, 2023 | -533.40% |
| Jun 30, 2023 | -912.49% |
| Mar 31, 2023 | -417.72% |
| Dec 31, 2022 | -675.89% |
| Sep 30, 2022 | -747.26% |
| Jun 30, 2022 | -614.08% |
| Mar 31, 2022 | 1,055.00% |